Search filters

List of works by Weina Sun

A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine

scientific article published on 17 December 2020

A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine

scientific article published on 31 July 2020

A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial

scientific article published on 07 December 2020

A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains

scientific article published on 19 July 2019

An Inactivated Influenza Virus Vaccine Approach to Targeting the Conserved Hemagglutinin Stalk and M2e Domains

scientific article published on 18 September 2019

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations

scientific article published on 4 April 2018

Antibody responses towards the major antigenic sites of influenza B virus hemagglutinin in mice, ferrets and humans

article

Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance

Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model

scientific article published on 29 March 2017

Development of Influenza B Universal Vaccine Candidates Using the "Mosaic" Hemagglutinin Approach

scientific article published on 29 May 2019

Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals

scientific article published on 03 June 2020

Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase

scientific article published on 28 August 2019

Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice

scholarly article by Felix Broecker published in October 2018

Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial

scientific article published on 17 October 2019

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate

scientific article published on 21 November 2020

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate

scientific article published on 26 July 2020

Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts

scientific article published on 06 December 2019